In a post on Friday, Elon Musk, the billionaire whos been tapped to cut government spending in the Trump administration, suggested making GLP-1 drugs available at low cost to Americans who wish to use them would greatly improve health and reduce health-care costs. Musk said in October of 2022 he had been using Wegovy
Market Segmentation: The GLP-1 market is segmented by type of molecule, active compound used, type of glp-1 agonist drugs, type of agonist, route of administration, target indication
As manufacturers expand production capacity and competition intensifies, lower pricing could help make GLP-1 therapies accessible to a larger patient population, supporting continued market growth despite potential pressure on revenue per prescription
Price range: $89.99 through $119.99 Epithalon Select options This product has multiple variants
Researchers may consider investigating either separately or combining both to study how they interact in settings like injury recovery
The following day (day 0, from 09:00 to about 15:00 h), rats were anesthetized, using an i.m